Franklin Resources’s Crescent Biopharma, Inc. Common Stock CBIO Stock Holding History

Franklin Resources’s Portfolio CBIO Stock Details CBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-958	Closed	-$226K	–	2900
2023 Q4	$226K	Sell	958 -1	-0.1%	-$236	﹤0.01%	2297
2023 Q3	$144K	Sell	959 -248	-21%	-$37.2K	﹤0.01%	2389
2023 Q2	$210K	Hold	1,207	–	–	﹤0.01%	2349
2023 Q1	$152K	Hold	1,207	–	–	﹤0.01%	2054
2022 Q4	$366K	Hold	1,207	–	–	﹤0.01%	1790
2022 Q3	$67K	Buy	1,207 +14	+1%	+$777	﹤0.01%	2165
2022 Q2	$71K	Sell	1,193 -420	-26%	-$25K	﹤0.01%	2197
2022 Q1	$184K	Buy	1,613 +10	+0.6%	+$1.14K	﹤0.01%	2174
2021 Q4	$231K	Sell	1,603 -4	-0.2%	-$576	﹤0.01%	2181
2021 Q3	$352K	Buy	+1,607	New	+$352K	﹤0.01%	2024
2019 Q3	–	Sell	-17,188	Closed	-$20.5M	–	1534
2019 Q2	$20.5M	Sell	17,188 -419	-2%	-$499K	0.01%	740
2019 Q1	$21.9M	Sell	17,607 -2,073	-11%	-$2.58M	0.01%	723
2018 Q4	$18.6M	Sell	19,680 -483	-2%	-$457K	0.01%	719
2018 Q3	$29M	Sell	20,163 -1,475	-7%	-$2.12M	0.01%	677
2018 Q2	$34.9M	Buy	21,638 +556	+3%	+$897K	0.02%	625
2018 Q1	$34.2M	Buy	21,082 +1,788	+9%	+$2.9M	0.02%	632
2017 Q4	$32.4M	Buy	19,294 +703	+4%	+$1.18M	0.02%	661
2017 Q3	$26M	Hold	18,591	–	–	0.01%	723
2017 Q2	$20.7M	Buy	18,591 +8,591	+86%	+$9.59M	0.01%	779
2017 Q1	$5.43M	Hold	10,000	–	–	﹤0.01%	1090
2016 Q4	$6.1M	Sell	10,000 -100	-1%	-$61K	﹤0.01%	1054
2016 Q3	$7.22M	Hold	10,100	–	–	﹤0.01%	1038
2016 Q2	$7.34M	Hold	10,100	–	–	﹤0.01%	1025
2016 Q1	$6.02M	Hold	10,100	–	–	﹤0.01%	1067
2015 Q4	$5.78M	Buy	10,100 +1,497	+17%	+$856K	﹤0.01%	1106
2015 Q3	$4.82M	Sell	8,603 -316	-4%	-$177K	﹤0.01%	1150
2015 Q2	$7.09M	Hold	8,919	–	–	﹤0.01%	1110
2015 Q1	$7.42M	Hold	8,919	–	–	﹤0.01%	1104
2014 Q4	$6.42M	Sell	8,919 -261	-3%	-$188K	﹤0.01%	1133
2014 Q3	$6.37M	Sell	9,180 -1,547	-14%	-$1.07M	﹤0.01%	1134
2014 Q2	$9.04M	Buy	10,727 +1,780	+20%	+$1.5M	﹤0.01%	1077
2014 Q1	$14.6M	Buy	+8,947	New	+$14.6M	0.01%	931